Menlo, Vanda see mixed results after missing primary endpoints in pruritus trials Feb. 26, 2020 By Michael Fitzhugh Readouts from two ambitious pruritus trials this week yielded starkly different reactions from investors seeking broader meaning in the outcomes.Read More
Tradipitant demonstrates antipruritic effect in mild atopic dermatitis in phase III EPIONE study Feb. 26, 2020
RSS